Max Robotics — Global Service Robot Directory + US Certification

About

Dr. E. Fortier is a urologic surgeon whose research focuses on the intersection of minimally invasive therapies and radical surgery for prostate cancer. Her most cited work investigates the feasibility of performing radical prostatectomy following vascular targeted photodynamic therapy (VTP) with padeliporfin, a novel treatment for localized disease. In this pivotal 2018 study, which has garnered 26 citations, Dr. Fortier demonstrated that VTP does not preclude subsequent surgical intervention, providing critical evidence for treatment sequencing in prostate cancer management. Her research addresses a key clinical question: whether non-ablative therapies compromise future surgical outcomes. By evaluating both functional and oncologic results, Dr. Fortier has helped establish safety parameters for patients who may require salvage prostatectomy after failed VTP. Her work contributes to the growing paradigm of multimodal, patient-tailored approaches in urologic oncology, bridging the gap between emerging photodynamic technologies and established surgical standards. Dr. Fortier’s findings offer reassurance to clinicians and patients considering VTP as a first-line option, knowing that radical prostatectomy remains a viable salvage strategy.